Accelerating drug discovery - Although the evolution of '-omics' methodologies is still in its infancy, both the pharmaceutical industry and patients could benefit from their implementation in the drug development process

被引：79

作者：

Kraljevic, S ^{[1
]}

Stambrook, PJ

Pavelic, K

机构：

[1] Rudjer Boskovic Inst, Div Mol Med, Lab Funct Genom, Zagreb, Croatia

[2] Univ Cincinnati, Med Ctr, Dept Cell Biol Neurobiol & Anat, Cincinnati, OH 45267 USA

来源：

EMBO REPORTS | 2004年 / 5卷 / 09期

关键词：

D O I：

10.1038/sj.embor.7400236

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：837 / 842

页数：6

共 31 条

[1] Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies [J].

Aardema, MJ ;

MacGregor, JT .

MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2002, 499 (01) :13-25

[2] Identification of putative gene-based markers of renal toxicity [J].

Amin, RA ;

Vickers, AE ;

Sistare, F ;

Thompson, KL ;

Roman, RJ ;

Lawton, M ;

Kramer, J ;

Hamadeh, HK ;

Collins, J ;

Grissom, S ;

Bennett, L ;

Tucker, CJ ;

Wild, S ;

Kind, C ;

Oreffo, V ;

Davis, JW ;

Curtiss, S ;

Naciff, JM ;

Cunningham, M ;

Tennant, R ;

Stevens, J ;

Car, B ;

Bertram, TA ;

Afsharil, CA .

ENVIRONMENTAL HEALTH PERSPECTIVES, 2004, 112 (04) :465-479

[3]

Ball CA, 2002, SCIENCE, V298, P539

[4] Proteomics: new perspectives, new biomedical opportunities [J].

Banks, RE ;

Dunn, MJ ;

Hochstrasser, DF ;

Sanchez, JC ;

Blackstock, W ;

Pappin, DJ ;

Selby, PJ .

LANCET, 2000, 356 (9243) :1749-1756

[5] Toxicogenomics, drug discovery, and the pathologist [J].

Boorman, GA ;

Anderson, SP ;

Casey, WM ;

Brown, RH ;

Crosby, LM ;

Gottschalk, K ;

Easton, M ;

Ni, H ;

Morgan, KT .

TOXICOLOGIC PATHOLOGY, 2002, 30 (01) :15-27

[6] Minimum information about a microarray experiment (MIAME) - toward standards for microarray data [J].

Brazma, A ;

Hingamp, P ;

Quackenbush, J ;

Sherlock, G ;

Spellman, P ;

Stoeckert, C ;

Aach, J ;

Ansorge, W ;

Ball, CA ;

Causton, HC ;

Gaasterland, T ;

Glenisson, P ;

Holstege, FCP ;

Kim, IF ;

Markowitz, V ;

Matese, JC ;

Parkinson, H ;

Robinson, A ;

Sarkans, U ;

Schulze-Kremer, S ;

Stewart, J ;

Taylor, R ;

Vilo, J ;

Vingron, M .

NATURE GENETICS, 2001, 29 (04) :365-371

[7] Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells [J].

Burczynski, ME ;

McMillian, M ;

Ciervo, J ;

Li, L ;

Parker, JB ;

Dunn, RT ;

Hicken, S ;

Farr, S ;

Johnson, MD .

TOXICOLOGICAL SCIENCES, 2000, 58 (02) :399-415

[8] Toxicogenomics: a new revolution in drug safety [J].

Castle, AL ;

Carver, MR ;

Mendrick, DL .

DRUG DISCOVERY TODAY, 2002, 7 (13) :728-736

[9] Proteomics in postgenomic neuroscience: the end of the beginning [J].

Choudhary, J ;

Grant, SGN .

NATURE NEUROSCIENCE, 2004, 7 (05) :440-445

[10] Comprehensive survey of combinatorial library synthesis: 2001 [J].

Dolle, RE .

JOURNAL OF COMBINATORIAL CHEMISTRY, 2002, 4 (05) :369-418

← 1 2 3 4 →